Found 114 articles for: "COVID-19"
A Novel Systems-Wide Approach in Addressing Acne with a Multi-Targeting Nutraceutical
March 2024 | Volume 23 | Issue 3 | Original Article | 160 | Copyright © March 2024
Acne vulgaris (AV) is one of the top concerns dermatologists encounter from women. Until now, therapies addressing AV have largely centered around, and have been successful at, targeting the path...
Read MoreComplementary and Alternative Medicine for Hidradenitis Suppurativa Discussed on TikTok: A Cross-Sectional Analysis
March 2024 | Volume 23 | Issue 3 | Editorials | e93 | Copyright © March 2024
Background: Hidradenitis suppurativa (HS) is a painful, chronic inflammatory skin disease that negatively affects patient quality of life, and conventional treatments are variabl...
Read MoreHalobetasol Propionate 0.01% and Tazarotene 0.045% Lotion With a Ceramide-Containing Moisturizer in Adults With Psoriasis
February 2024 | Volume 23 | Issue 2 | Original Article | 50 | Copyright © February 2024
Introduction: Moisturizers are often used as adjuvant therapy for psoriasis to assist with rehydration and skin barrier restoration. Fixed-combination halobetasol propionate 0.01...
Read MoreTeledermatology Platforms Usage and Barriers: A Cross-Sectional Analysis of United States-Based Dermatologists Pre- and Post-COVID-19
February 2024 | Volume 23 | Issue 2 | Editorials | e64 | Copyright © February 2024
Background: During the global COVID-19 pandemic, dermatologists increasingly adopted teledermatology to facilitate patient care.Objective: To identi...
Read MoreThe Pediatric Dermatologist's View of Pediatric Vitiligo
February 2024 | Volume 23 | Issue 2 | Editorials | e77 | Copyright © February 2024
Background: No guidelines exist for pediatric vitiligo.Objective: To identify practice patterns of pediatric dermatologists treating vitiligo....
Read MoreAtopic Dermatitis as a Paradoxical Reaction to Secukinumab in a Patient With Plaque Psoriasis
February 2024 | Volume 23 | Issue 2 | Case Reports | 97 | Copyright © February 2024
Paradoxical reactions to biologic agents used in the treatment of psoriasis are rare but have been reported with tumor necrosis factor (TNF) blockers and, more recently, with interleukin (IL)-17A...
Read MoreEffectiveness and Safety of Sculptra Poly-L-Lactic Acid Injectable Implant in the Correction of Cheek Wrinkles
January 2024 | Volume 23 | Issue 1 | Original Article | 1297 | Copyright © January 2024
Background: The current study evaluated the effectiveness and safety of Sculptra injectable poly-L-lactic acid (PLLA-SCA) treatment in correcting cheek wrinkles compared wit...
Read MoreFactors Impacting New Drug Adoption in the Clinical Setting: A Survey of Dermatologists
January 2024 | Volume 23 | Issue 1 | Editorials | 1362 | Copyright © January 2024
Off-Label Use of Janus Kinase Inhibitors in Inflammatory Cutaneous Diseases
December 2023 | Volume 22 | Issue 12 | Original Article | 1183 | Copyright © December 2023
Dysregulation of Janus kinase (JAK) pathways from uncontrolled cytokine signaling comprises the pathological basis for many complex inflammatory cutaneous disorders. Oral JAK inhibitors, upadacit...
Read MoreCryosurgery and 5-Fluorouracil Combination Therapy for Treatment of Bowen's Disease and Superficial Basal Cell Carcinoma
December 2023 | Volume 22 | Issue 12 | Original Article | 1166 | Copyright © December 2023
Background: Non-melanoma skin cancer (NMSC), which includes both Bowen's disease (BD) and superficial basal cell carcinoma (sBCC), is the most commonly diagnosed cancer in Canada...
Read MoreUnderrepresented Groups and Perceived Educational Barriers for Residency and Fellowship Success
December 2023 | Volume 22 | Issue 12 | Original Article | 1210 | Copyright © December 2023
Background: The study aimed to compare barriers perceived by medical students and resident physicians identifying as of underrepresented groups in medicine (UIM) and/or as sexual...
Read MoreRecombinant Zoster Vaccine Reduces 3-Year Cardiovascular Risk: Insights From a Multi-Centered Database
December 2023 | Volume 22 | Issue 12 | Original Article | 1178 | Copyright © December 2023
Background: Herpes zoster increases the risk for stroke and myocardial infarction. Zoster vaccination's impact on this risk is understudied. This retrospective work sought to det...
Read MoreHome Is Where the Match Is: Mentorship and Dermatology Residency Match Trends Before and During the COVID-19 Pandemic
December 2023 | Volume 22 | Issue 12 | Editorials | e44 | Copyright © December 2023
Tocilizumab Treatment in COVID-19 Patients: Comparing Cutaneous Disease and Adverse Drug Effects
December 2023 | Volume 22 | Issue 12 | Editorials | e42 | Copyright © December 2023
Actemra (tocilizumab) received emergency use authorization for the treatment of coronavirus disease 2019 (COVID-19) in June 2021. Literature has linked numerous cutaneous adverse effects to tocil...
Read MoreTelemedicine Versus Teledermatology Usage and Perception Among US-Based Physicians: A Survey Study
November 2023 | Volume 22 | Issue 11 | Features | e4 | Copyright © November 2023
The COVID-19 pandemic has sparked an increase in focus and use of telemedicine in several patient care settings. This survey study was distributed to actively practicing US-based physicians and e...
Read MorePerceived Barriers to Career Advancement: Medical Students and Resident Physicians
November 2023 | Volume 22 | Issue 11 | Features | e17 | Copyright © November 2023
Background: The path to becoming a physician is challenging, with various barriers influencing medical student and resident physician residency and fellowship training career dec...
Read MoreIndividual Article: A Novel 3-Step Over-the-Counter Eczema Regimen Improves Eczema Severity, Itch, and Life Quality: Randomized Study
October 2023 | Volume 22 | Issue 10 | Supplement Individual Articles | SF388641s21 | Copyright © October 2023
Background: Eczema, or atopic dermatitis (AD), is a chronic relapsing skin disease associated with unpredictable flares of erythema, rash, and pruritus. AD arises from a combinat...
Read MoreIndividual Article: Brodalumab Is an Efficacious, Safe, and Cost-Effective IL-17 Receptor Blocker for the Treatment of Moderate-to-Severe Plaque Psoriasis: 2023 Update
October 2023 | Volume 22 | Issue 10 | Supplement Individual Articles | SF378632s5 | Copyright © October 2023
Psoriasis remains a highly prevalent condition in the United States and worldwide. Preclinical research has been triumphant in elucidating the critical immunological pathways involved in psoriasi...
Read MoreParticipant Satisfaction of a Community-based Telehealth Clinic for Atopic Dermatitis
October 2023 | Volume 22 | Issue 10 | Editorials | 1066 | Copyright © October 2023
Atopic dermatitis (AD), a chronic, relapsing inflammatory disease that affects more than 30 million children and adults in the US, disproportionally impacts African American (AA) and Hispanic children...
Read MoreComparing the Efficacy for Pulse Versus Continuous Dose Terbinafine Therapy in Patients With Onychomycosis
October 2023 | Volume 22 | Issue 10 | Original Article | 1017 | Copyright © October 2023
Media and other results for: "COVID-19"